Cardiac-targeting peptide nanozyme AS@PB-CTP improves heart function and reduces inflammation in ICI-myocarditis.
Cardiac-targeting peptide-modified Prussian blue nanozymes loaded with Astragaloside IV for efficient ICI-myocarditis therapy.
Abstract
AS@PB-CTP nanozyme, with Astragaloside IV and a cardiac-targeting peptide, improved heart function and reduced inflammation in a preclinical ICI-myocarditis model.